Tens of thousands of people took to the streets of Boston on Saturday to protest a "free speech" rally featuring far-right speakers a week after a woman was killed at a Virginia white-supremacist demonstration.
Little bets can make for big gains when it comes to independent films, and Amazon deserves more credit for how it funds winners than most investors are willing to give.
The Netherlands is taking a drastically different approach to cultivating innovation in biotech. The United States could learn a thing or two.
Social Security's inflationary tether has been heading in the wrong direction in recent months, which could mean only a small raise for beneficiaries next year.
Find out how some Americans are investing five figures for retirement each year. You might learn some ways to turbocharge your own savings.
Among the high-yield stocks poised for growth are tech industry stalwarts IBM, Microsoft, and Intel.
The industry prepares for an eclipse, and a number of projects were sold.
The Myers-Briggs Type Indicator text is widely used in the business world and elsewhere, and you may find it fascinating to learn about your "type" -- but there's also evidence that the types don't really matter. Here are some surprising things to know about Myers-Briggs.
With shares of both tech leaders down in recent weeks on underwhelming guidance, which should investors buy today?
American Girl has made its first Native Hawaiian doll.
Do investors have too much faith in AMD’s ability to counter NVIDIA and Intel?
Billionaire investor Carl Icahn, who resigned Friday from an unpaid post as President Donald Trump's adviser on deregulation efforts, stepped down as The New Yorker was preparing to publish a lengthy article detailing Icahn's potential conflicts of interest and questioning the legality of his actions.
SINA's reliance on Weibo could hurt long-term growth.
These three stocks offer some mouth-watering yields.
Shares of Geron Corporation, Rigel Pharmaceuticals Inc., and Agenus Inc. appear to be trading for much less than they could be worth.
Innovation? Check. Safe dividends? Check. Here’s why Royal Dutch Shell, Albemarle, and Universal Display Corporation are right for any income investor.
The fast-casual chain is struggling with a challenging combination of falling comps and rising costs.
Netflix has long dominated streaming, but competitors are now offering compelling content that may take a bite out of the company's growth.
New Hampshire will be getting $1 million from EpiPen maker Mylan as part of a national settlement.
Mexican authorities say an explosion at an illegal fuel pipeline tap has killed a person and injured five more in the Gulf coast state of Veracruz.
If you want to start investing for your retirement, here's what you need to know before you get started.
Which of these mature tech companies has more room to run?
SpaceX is not public, and may never IPO -- but you can still own a piece of it.
Even for a business with 2 billion users, this is a huge expense.
A strengthening U.S. economy and a low unemployment rate have workers feeling more confident about their jobs and saving for retirement.
The application delivery and security specialist reported slowing growth, but the recent pullback could be an opportunity.
Celldex Therapeutics, Insys Therapeutics, and Novavax might not be so cheap over the long run.